Blood-brain barrier disruption and delivery of irinotecan in a rat model using a clinical transcranial MRI-guided focused ultrasound system
Abstract We investigated controlled blood-brain barrier (BBB) disruption using a low-frequency clinical transcranial MRI-guided focused ultrasound (TcMRgFUS) device and evaluated enhanced delivery of irinotecan chemotherapy to the brain and a rat glioma model. Animals received three weekly sessions...
Guardado en:
Autores principales: | Nathan McDannold, Yongzhi Zhang, Jeffrey G. Supko, Chanikarn Power, Tao Sun, Natalia Vykhodtseva, Alexandra J. Golby, David A. Reardon |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dbbc08312ca148409c6d22571344c92a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Transcranial focused ultrasound for epilepsy
por: Ellen Bubrick, et al.
Publicado: (2021) -
Blood–brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound
por: Nir Lipsman, et al.
Publicado: (2018) -
Nanomedicine developments in the treatment of metastatic pancreatic cancer: focus on nanoliposomal irinotecan
por: Ko AH
Publicado: (2016) -
Preoperative imaging findings in patients undergoing transcranial magnetic resonance imaging-guided focused ultrasound thalamotomy
por: Cesare Gagliardo, et al.
Publicado: (2021) -
Intrinsic functional neuron-type selectivity of transcranial focused ultrasound neuromodulation
por: Kai Yu, et al.
Publicado: (2021)